vaccines

President Donald Trump has signed an order that calls for fewer childhood vaccines and also recommends splitting the mumps, measles and rubella (MMR) shots.

“Decades ago, children received only a small fraction of the vaccines required today,” Trump said on Monday. “In those times, people were much healthier and of course the high rates of autism now observed did not exist.”

The president has long cast doubt on the safety of MMR vaccines, but multiple studies have found no connection between the shots and autism.

The order also recommends that the number of childhood vaccines drop to 11 from the existing 18 recommended by the American Academy of Pediatrics (AAP).

Speaking in the Oval Office, Trump said that his administration “is recognising gold standard childhood vaccine recommendations for only 11 core vaccinations against the most serious and dangerous diseases”.

The immunisations recommended for all children under the order are for measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus, and varicella or chicken pox.

“We’re reducing them,” Trump said. “It’s not only that you’re doing fewer vaccines, or jabs, as they say, but you’re doing them in a series of visits to the doctor.”

The president suggested that the MMR vaccine could be “quite lethal” if given at once. He compared it to pouring a bottle of soda into a child’s body.

Experts say that allowing time between jabs means children are more likely to contract diseases in the interim or that they are more likely to miss appointments if there are multiple shots.

According to the Centers for Disease Control and Prevention, external (CDC), there is “no published scientific evidence that shows any benefit in separating the combination MMR vaccine into three individual shots”.

The agency says “most people who get MMR vaccine do not have any serious problems with it”, and that getting the vaccine “is much safer than getting measles, mumps, or rubella”.

Trump’s Secretary of Health and Human Services (HHS) Robert F Kennedy Jr said the proposed changes were meant to give parents choice, not prohibit access to childhood vaccines.

The federal government does not have the authority to implement the new recommendations. Shots that are required for school attendance are set at the state level.

Dr Andrew Racine, president of the American Academy of Pediatrics, called Trump’s executive order “disheartening” and “dangerous”, pointing out it comes as measles cases reach a 35-year high in the US. Measles cases have also been rising globally.

“Instead of ensuring every family can access life-saving vaccines for measles, influenza, RSV and more, federal leaders are once again spreading misleading claims,” Racine said in a statement on Monday.

He said there was no new evidence to justify the significant changes, adding that the order was not based on “gold-standard science”.

“Delaying or skipping shots is risky, especially as measles continues to spread and children go back to school,” Racine said.

Republican Senator Bill Cassidy also admonished Trump’s executive order on Monday, labelling it “wrong”.

“The President does not have the expertise to make these changes,” Cassidy, who is a physician, wrote on social media. “Vaccines are overwhelmingly safe. Vaccines are effective. Vaccines DO NOT cause autism.”

The lawmaker, who chairs the Senate health committee, urged parents to “listen to their child’s pediatrician about vaccines rather than listening to an inaccurate executive order”.

Experts fear that if parents refrain from getting their children vaccinated as a result of the discredited idea that childhood vaccines are linked to autism, it risks the re-emergence of diseases like measles.

Multiple studies have found no link between the MMR vaccine and autism. A recent high-quality study from Denmark in 2019 looked at 657,461 children and concluded that the data did not support the MMR vaccine causing or triggering autism.

On its website, the US CDC recommends that two doses of the combined MMR vaccine be given to children, starting with the first dose at 12-15 months and the second between the ages of four and six.

How often and how many vaccines children in the US receive is based on the times when vaccines will work best with their immune systems and when they are most vulnerable to certain diseases, according to the AAP.

There is no medical reason to delay or skip recommended immunisations, the AAP says.

1 of 3 | Health and Human Services Secretary Robert F. Kennedy Jr. speaks before President Donald Trump signs an executive order that reevaluates childhood vaccines in the Oval Office of the White House in Washington, D.C., on Monday. While the executive order still recommends childhood vaccines for 11 diseases, including measles and polio, it calls for limiting vaccines for other diseases, like hepatitis A and B and meningococcal disease, to high-risk populations. Photo by Bonnie Cash/UPI | License Photo

Aug. 10 (UPI) — President Donald Trump signed an executive order Monday to reduce the number of vaccines recommended for children.

At the signing of the executive order, Trump shared claims that childhood vaccines are linked to an increase in autism diagnoses without evidence. Health and Human Services Secretary Robert F. Kennedy Jr., who was present for the signing, has maintained this stance as well.

Scientific research into potential links between vaccines and autism have consistently found no connection.

Trump’s executive order also advises breaking up MMR vaccines for the mumps, measles and rubella, a vaccine Trump called “quite lethal,” into three separate vaccines. In the more than 50 years since the MMR vaccine was developed there has been no evidence that it is deadly.

“Nothing bad can happen from what we’re doing,” Trump said.

Vaccine advocates and researchers have warned that reducing the distribution of childhood vaccines will make children more vulnerable to disease. Sen. Bill Cassidy, R-La., who is a medical doctor, posted on social media that the executive order “is wrong.”

“The President does not have the expertise to make these changes,” Cassidy wrote. “Vaccines are overwhelmingly safe. Vaccines are effective. Vaccines DO NOT cause autism. Breaking up vaccines will mean children have to get more shots to get the same protection, not fewer shots. It will increase hesitancy and make children less safe.”

Trump acknowledged the increased burden of breaking up vaccines when addressing reporters after the signing.

“It’s inconvenient. It’s five stops but it’s something that I think will have a huge impact on autism,” Trump said.

Supported by the World Health Organization and Africa CDC, India has taken on the urgent and unique task to engage in the production of a vaccine for the Ebola virus, the deadly disease that broke out in the Democratic Republic of Congo in mid-May 2026. Following the Ebola infection cases, many countries have broader steps to reinforce disease surveillance and strict border control mechanisms amid rising regional risks, especially in the Central African region.

WHO declared, in May, the outbreak a ‘public health emergency’ of international concern, underscoring the need for monitoring measures of cross-border human movements and the possibility to control transmission. Many countries have adopted and reviewed screening procedures and coordination designed to detect and contain any suspected cases.

The Serum Institute of India (SII) is partnering with the University of Oxford and CEPI to develop a new vaccine candidate targeting the Bundibugyo strain of the Ebola virus. Because no approved vaccines currently exist for this specific strain, the SII is fast-tracking production using the viral vector platform. 

Fast-Tracked Vaccine Development

The Target: The vaccine candidate (ChAdOx1 BDBV) is designed to prevent the rare Bundibugyo ebolavirus, which is currently causing outbreaks in Central Africa.

The Technology: It utilizes the same viral vector platform used for the Oxford/AstraZeneca COVID-19 vaccine, allowing for rapid scaling and manufacturing once the clinical-grade material is ready. 

Timeline: The World Health Organization (WHO) has fast-tracked the assessment process, with clinical-grade doses expected to be available for trial testing. 

Indian Preparedness & Protocols

Zero Active Cases: India has not reported any active cases of the Ebola virus.

Preventive Measures: Indian health authorities and airports have placed specialized facilities on high alert. This includes preventive screening and isolation protocols for any suspected cases or individuals traveling from affected regions like the Democratic Republic of Congo and Uganda.

Global efforts accelerate vaccine development.

Scientists and vaccine manufacturers are now racing to design, test, manufacture, and deploy vaccines that could help prevent this outbreak from persisting for several years, as previous outbreaks have. Medical experts across the world maintain that the Ebola epidemic is a global threat. 

Director-General Tedros Adhanom Ghebreyesus flew to the DRC and visited the province of Ituri. After the visit, he said, “A Bundibugyo vaccine could help to control this epidemic and strengthen preparedness for future outbreaks.”

Notwithstanding the challenges, Ghebreyesus expressed confidence and optimism that the outbreak would be stopped. Africa Centres for Disease Control and Prevention director general Jean Kaseya later confirmed that the vaccines will be manufactured by the Serum Institute of India, underscoring the growing confidence to ensure health sovereignty and to contain further spread of Ebola.

Different virus, different challenge

Since the outbreak, over 1500 suspected cases and 650 deaths have been reported in the Democratic Republic of the Congo (DRC) and Uganda. According to medical reports, this newest outbreak is being caused by the Bundibugyo virus, a more recently discovered species that is less lethal than Zaire but has no approved vaccines or treatments. With the majority of cases impacting the DRC, this marks the country’s 17th Ebola outbreak since the discovery of the virus on the Ebola River in 1976. 

Despite the huge untapped resources, the world’s deadliest and most complex humanitarian crises have been unfolding for decades in the Democratic Republic of the Congo, located in central Africa.